Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma according to ECOG performance status: A subanalysis from the SHARP trial

被引:0
|
作者
Raoul, J.
Santoro, A.
Beaugrand, M.
Marrero, J. A.
Moscovici, M.
Shan, M.
Nadel, A.
Voliotis, D.
Bruix, J.
Llovet, J. M.
机构
[1] Ctr Eugene Marquis, Rennes, France
[2] Ist Clin Humanitas, Rozzano, Italy
[3] Hop Jean Verdier, Bondy, France
[4] Univ Michigan, Ann Arbor, MI 48109 USA
[5] Bayer Schering Pharma, Milan, Italy
[6] Bayer HealthCare Pharmaceut, West Haven, CT USA
[7] Bayer Schering Pharma, Wuppertal, Germany
[8] Barcelona Clin, Liver Canc Grp, Barcelona, Spain
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
4587
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma and vascular invasion or extrahepatic spread: A subanalysis from the SHARP trial
    Sherman, M.
    Mazzaferro, V.
    Amadori, D.
    Seitz, J.
    Moscovici, M.
    Shan, M.
    Nadel, A.
    Voliotis, D.
    Llovet, J. M.
    Bruix, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [2] Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma and prior anti-tumor therapy: A subanalysis from the sharp trial
    Galle, P.
    Blanc, J.
    Van Laethem, J-L.
    Marrero, J.
    Beaugrand, M.
    Moscovici, M.
    Shan, M.
    Nadel, A.
    Voliotis, D.
    Bruix, J.
    Llovet, J. M.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S372 - S372
  • [3] Efficacy and safety of sorafenib in patients with advanced HCC and prior anti-tumor therapy: a subanalysis from the SHARP trial
    Galle, P.
    Woerns, M.
    Blanc, J.
    Van Laethem, J.
    Marrero, J.
    Beaugrand, M.
    Moscovici, M.
    Shan, M.
    Nadel, A.
    Voliotis, D.
    Bruix, J.
    Llovet, J.
    ONKOLOGIE, 2010, 33 : 84 - +
  • [4] Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma according to baseline status: Subset analyses of the phase III Sorafenib Asia-Pacific trial
    Cheng, Ann-Lii
    Guan, Zhongzhen
    Chen, Zhendong
    Tsao, Chao-Jung
    Qin, Shukui
    Kim, Jun Suk
    Yang, Tsai-Sheng
    Tak, Won Young
    Pan, Hongming
    Yu, Shiying
    Xu, Jianming
    Fang, Fang
    Zou, Jessie
    Lentini, Giuseppe
    Voliotis, Dimitris
    Kang, Yoon-Koo
    EUROPEAN JOURNAL OF CANCER, 2012, 48 (10) : 1452 - 1465
  • [5] EFFICACY AND SAFETY OF SORAFENIB IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC): SUBANALYSIS OF SHARP TRIAL BASED ON BARCELONA CLINIC LIVER CANCER (BCLC) STAGE
    Bruix, J.
    Raoul, J. L.
    Sherman, M.
    Shan, M.
    Lentini, G.
    Nadel, A.
    Voliotis, D.
    Llovet, J. M.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S28 - S29
  • [6] Sorafenib therapy in advanced hepatocellular carcinoma: the SHARP trial
    Rimassa, Lorenza
    Santoro, Armando
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (06) : 739 - 745
  • [7] Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial
    Bruix, Jordi
    Raoul, Jean-Luc
    Sherman, Morris
    Mazzaferro, Vincenzo
    Bolondi, Luigi
    Craxi, Antonio
    Galle, Peter R.
    Santoro, Armando
    Beaugrand, Michel
    Sangiovanni, Angelo
    Porta, Camillo
    Gerken, Guido
    Marrero, Jorge A.
    Nadel, Andrea
    Shan, Michael
    Moscovici, Marius
    Voliotis, Dimitris
    Llovet, Josep M.
    JOURNAL OF HEPATOLOGY, 2012, 57 (04) : 821 - 829
  • [8] Efficacy and safety of sorafenib in elderly patients with advanced hepatocellular carcinoma
    Marta, Guilherme Nader
    da Fonseca, Leonardo G.
    Braghiroli, Maria Ignez
    Moura, Fernando
    Hoff, Paulo M.
    Sabbaga, Jorge
    CLINICS, 2021, 76 : 1 - 6
  • [9] SAFETY AND EFFICACY OF SORAFENIB FOR ADVANCED HEPATOCELLULAR CARCINOMA
    Sacco, P. C.
    De Sanctis, R.
    Quadrini, S.
    Gori, B.
    Del, Signore E.
    Stumbo, L.
    Tedeschi, M.
    Falbo, P. T.
    Fulvi, A.
    Grassi, P.
    Sollami, R.
    Basile, M. L.
    Di Seri, M.
    ANNALS OF ONCOLOGY, 2009, 20
  • [10] Efficacy and safety of sorafenib in patients with alcohol-related hepatocellular carcinoma: A sub-analysis from the SHARP trial
    Craxi, A.
    Porta, C.
    Sangiovanni, A.
    Seitz, J.
    Moscovici, M.
    Shan, M.
    Nadel, A.
    Voliotis, D.
    Bruix, J.
    Llovet, J. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)